Good Sense Children's Pain and Fever acetaminophen oral suspension recall
Perrigo is recalling Good Sense Children's Pain and Fever acetaminophen oral suspension (160 mg/5 ml) in 4 FL OZ bottles due to contaminated excipient used during manufacturing. The recalled batch 1CK0963 (expiration 12/31/2022) was distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall. No illnesses or injuries are reported in the source text. The hazard is manufacturing deviation with a contaminated excipient, which constitutes a precautionary recall. Per the rubric, Class II recalls without reported harm typically score 2.
Plain-English summary
Perrigo Company PLC is recalling Good Sense Children's Pain and Fever acetaminophen oral suspension, bubble gum flavored, 160 mg/5 ml in 4 FL OZ (118 mL) bottles. The product was manufactured using a contaminated excipient that was itself recalled by the excipient supplier.
The recalled product was distributed nationwide across the United States. Affected consumers should stop use and discard the product if they have the batch code 1CK0963 with expiration date 12/31/2022 (NDC 0113-0020-26).
Consumers with questions or who believe they have used this product should contact their healthcare provider. Reports of adverse events related to this recall can be reported to the FDA's MedWatch program.
The recalled product
- Product
- GOOD SENSE CHILDRENS PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- GOOD SENSE CHILDRENS PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Hazard
- contaminated-excipient
- cGMP-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK0963
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27